A citation-based method for searching scientific literature

Priya R Gupta, Rachel M Huckfeldt. J Neural Eng 2017
Times Cited: 17







List of co-cited articles
108 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Stephen Russell, Jean Bennett, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan Elci, Sarah McCague,[...]. Lancet 2017
783
47

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.
Robert E MacLaren, Markus Groppe, Alun R Barnard, Charles L Cottriall, Tanya Tolmachova, Len Seymour, K Reed Clark, Matthew J During, Frans P M Cremers, Graeme C M Black,[...]. Lancet 2014
536
35

Two-Year Results After AAV2-Mediated Gene Therapy for Choroideremia: The Alberta Experience.
Ioannis S Dimopoulos, Stephanie C Hoang, Alina Radziwon, Natalia M Binczyk, Miguel C Seabra, Robert E MacLaren, Rizwan Somani, Matthew T S Tennant, Ian M MacDonald. Am J Ophthalmol 2018
92
23

Visual Acuity after Retinal Gene Therapy for Choroideremia.
Thomas L Edwards, Jasleen K Jolly, Markus Groppe, Alun R Barnard, Charles L Cottriall, Tanya Tolmachova, Graeme C Black, Andrew R Webster, Andrew J Lotery, Graham E Holder,[...]. N Engl J Med 2016
149
23

Choroideremia Gene Therapy Phase 2 Clinical Trial: 24-Month Results.
Byron L Lam, Janet L Davis, Ninel Z Gregori, Robert E MacLaren, Aniz Girach, Jennifer D Verriotto, Belen Rodriguez, Potyra R Rosa, Xiaojun Zhang, William J Feuer. Am J Ophthalmol 2019
83
23


Effective delivery of large genes to the retina by dual AAV vectors.
Ivana Trapani, Pasqualina Colella, Andrea Sommella, Carolina Iodice, Giulia Cesi, Sonia de Simone, Elena Marrocco, Settimio Rossi, Massimo Giunti, Arpad Palfi,[...]. EMBO Mol Med 2014
149
23

Nanoparticle-based technologies for retinal gene therapy.
Jeffrey Adijanto, Muna I Naash. Eur J Pharm Biopharm 2015
50
23

Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
Richard G Weleber, Mark E Pennesi, David J Wilson, Shalesh Kaushal, Laura R Erker, Lauren Jensen, Maureen T McBride, Terence R Flotte, Margaret Humphries, Roberto Calcedo,[...]. Ophthalmology 2016
119
17

Choroideremia: a review of general findings and pathogenesis.
Razek Georges Coussa, Elias I Traboulsi. Ophthalmic Genet 2012
86
17

Technique of retinal gene therapy: delivery of viral vector into the subretinal space.
K Xue, M Groppe, A P Salvetti, R E MacLaren. Eye (Lond) 2017
80
17

Remodeling of the human retina in choroideremia: rab escort protein 1 (REP-1) mutations.
Samuel G Jacobson, Artur V Cideciyan, Alexander Sumaroka, Tomas S Aleman, Sharon B Schwartz, Elizabeth A M Windsor, Alejandro J Roman, Edwin M Stone, Ian M MacDonald. Invest Ophthalmol Vis Sci 2006
129
17

Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
Jean Bennett, Jennifer Wellman, Kathleen A Marshall, Sarah McCague, Manzar Ashtari, Julie DiStefano-Pappas, Okan U Elci, Daniel C Chung, Junwei Sun, J Fraser Wright,[...]. Lancet 2016
268
17

The Role of Gene Therapy in the Treatment of Retinal Diseases: A Review.
C Campa, C E Gallenga, E Bolletta, P Perri. Curr Gene Ther 2017
20
17

Long-term effect of gene therapy on Leber's congenital amaurosis.
James W B Bainbridge, Manjit S Mehat, Venki Sundaram, Scott J Robbie, Susie E Barker, Caterina Ripamonti, Anastasios Georgiadis, Freya M Mowat, Stuart G Beattie, Peter J Gardner,[...]. N Engl J Med 2015
474
17

Measurement and Reproducibility of Preserved Ellipsoid Zone Area and Preserved Retinal Pigment Epithelium Area in Eyes With Choroideremia.
Amir H Hariri, Swetha B Velaga, Aniz Girach, Michael S Ip, Phuc V Le, Byron L Lam, M Dominik Fischer, Eeva-Marja Sankila, Mark E Pennesi, Frank G Holz,[...]. Am J Ophthalmol 2017
43
17

Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.
Sophia Millington-Ward, Naomi Chadderton, Mary O'Reilly, Arpad Palfi, Tobias Goldmann, Claire Kilty, Marian Humphries, Uwe Wolfrum, Jean Bennett, Peter Humphries,[...]. Mol Ther 2011
108
17

Safety and efficacy of gene transfer for Leber's congenital amaurosis.
Albert M Maguire, Francesca Simonelli, Eric A Pierce, Edward N Pugh, Federico Mingozzi, Jeannette Bennicelli, Sandro Banfi, Kathleen A Marshall, Francesco Testa, Enrico M Surace,[...]. N Engl J Med 2008
17

Evaluation of Dose and Safety of AAV7m8 and AAV8BP2 in the Non-Human Primate Retina.
Pavitra S Ramachandran, Vivian Lee, Zhangyong Wei, Ji Yun Song, Giulia Casal, Therese Cronin, Keirnan Willett, Rachel Huckfeldt, Jessica I W Morgan, Tomas S Aleman,[...]. Hum Gene Ther 2017
78
17

Effect of gene therapy on visual function in Leber's congenital amaurosis.
James W B Bainbridge, Alexander J Smith, Susie S Barker, Scott Robbie, Robert Henderson, Kamaljit Balaggan, Ananth Viswanathan, Graham E Holder, Andrew Stockman, Nick Tyler,[...]. N Engl J Med 2008
17

Vectors and Gene Delivery to the Retina.
Arthur Planul, Deniz Dalkara. Annu Rev Vis Sci 2017
28
17

Vitreous: a barrier to nonviral ocular gene therapy.
Liesbeth Peeters, Niek N Sanders, Kevin Braeckmans, Koen Boussery, Johan Van de Voorde, Stefaan C De Smedt, Joseph Demeester. Invest Ophthalmol Vis Sci 2005
127
17

The molecular basis of human retinal and vitreoretinal diseases.
Wolfgang Berger, Barbara Kloeckener-Gruissem, John Neidhardt. Prog Retin Eye Res 2010
367
17

Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10.
Morgan L Maeder, Michael Stefanidakis, Christopher J Wilson, Reshica Baral, Luis Alberto Barrera, George S Bounoutas, David Bumcrot, Hoson Chao, Dawn M Ciulla, Jennifer A DaSilva,[...]. Nat Med 2019
287
17

The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Caroline F Peddle, Robert E MacLaren. Yale J Biol Med 2017
18
17

Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina.
Abhishek Sengupta, Antoine Chaffiol, Emilie Macé, Romain Caplette, Mélissa Desrosiers, Maruša Lampič, Valérie Forster, Olivier Marre, John Y Lin, José-Alain Sahel,[...]. EMBO Mol Med 2016
93
17

Vector platforms for gene therapy of inherited retinopathies.
Ivana Trapani, Agostina Puppo, Alberto Auricchio. Prog Retin Eye Res 2014
95
17

Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye.
Gerard A Rodrigues, Evgenyi Shalaev, Thomas K Karami, James Cunningham, Nigel K H Slater, Hongwen M Rivers. Pharm Res 2018
93
17

Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells.
Shahinaz Mahmood Shalaby, Mostafa K Khater, Aymara Mas Perucho, Sara A Mohamed, Inas Helwa, Archana Laknaur, Iryna Lebedyeva, Yutao Liu, Michael P Diamond, Ayman A Al-Hendy. Fertil Steril 2016
17
11

Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo.
Tanya Tolmachova, Oleg E Tolmachov, Alun R Barnard, Samantha R de Silva, Daniel M Lipinski, Nathan J Walker, Robert E Maclaren, Miguel C Seabra. J Mol Med (Berl) 2013
64
11

Pathogenic mechanisms and the prospect of gene therapy for choroideremia.
Ioannis S Dimopoulos, Stephanie Chan, Robert E MacLaren, Ian M MacDonald. Expert Opin Orphan Drugs 2015
28
11

Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus.
Vibha Anand, Duarte C Barral, Yong Zeng, Frank Brunsmann, Albert M Maguire, Miguel C Seabra, Jean Bennett. Vision Res 2003
43
11

The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A.
Maria I Patrício, Alun R Barnard, Christopher I Cox, Clare Blue, Robert E MacLaren. Mol Ther Methods Clin Dev 2018
11
18

Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina.
Maria I Patrício, Alun R Barnard, Harry O Orlans, Michelle E McClements, Robert E MacLaren. Mol Ther Nucleic Acids 2017
32
11

Retinal Degeneration in Choroideremia follows an Exponential Decay Function.
James W Aylward, Kanmin Xue, Maria I Patrício, Jasleen K Jolly, Jonathan C Wood, Jonathan Brett, Kirti M Jasani, Robert E MacLaren. Ophthalmology 2018
23
11

AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.
Vidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, Etiena Basner-Tschakarjan, Monika Kohnke, Aaron D Black, Krill Alexandrov, Shangzhen Zhou, Albert M Maguire, Daniel C Chung,[...]. PLoS One 2013
59
11

Correction of Monogenic and Common Retinal Disorders with Gene Therapy.
Jesse D Sengillo, Sally Justus, Thiago Cabral, Stephen H Tsang. Genes (Basel) 2017
31
11


Non-syndromic retinitis pigmentosa.
Sanne K Verbakel, Ramon A C van Huet, Camiel J F Boon, Anneke I den Hollander, Rob W J Collin, Caroline C W Klaver, Carel B Hoyng, Ronald Roepman, B Jeroen Klevering. Prog Retin Eye Res 2018
336
11

Recent advances and future prospects in choroideremia.
Martin S Zinkernagel, Robert E MacLaren. Clin Ophthalmol 2015
32
11

Retinal Gene Therapy: Surgical Vector Delivery in the Translation to Clinical Trials.
G Alex Ochakovski, K Ulrich Bartz-Schmidt, M Dominik Fischer. Front Neurosci 2017
55
11

Retinitis pigmentosa: genes and disease mechanisms.
Stefano Ferrari, Enzo Di Iorio, Vanessa Barbaro, Diego Ponzin, Francesco S Sorrentino, Francesco Parmeggiani. Curr Genomics 2011
326
11

Gene therapy for retinal disease.
Michelle E McClements, Robert E MacLaren. Transl Res 2013
46
11


Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey.
Luk H Vandenberghe, Peter Bell, Albert M Maguire, Cassia N Cearley, Ru Xiao, Roberto Calcedo, Lili Wang, Michael J Castle, Alexandra C Maguire, Rebecca Grant,[...]. Sci Transl Med 2011
143
11


Optogenetics.
Jens Duebel, Katia Marazova, José-Alain Sahel. Curr Opin Ophthalmol 2015
43
11

Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
Samuel G Jacobson, Artur V Cideciyan, Ramakrishna Ratnakaram, Elise Heon, Sharon B Schwartz, Alejandro J Roman, Marc C Peden, Tomas S Aleman, Sanford L Boye, Alexander Sumaroka,[...]. Arch Ophthalmol 2012
445
11

Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.
Artur V Cideciyan, Raghavi Sudharsan, Valérie L Dufour, Michael T Massengill, Simone Iwabe, Malgorzata Swider, Brianna Lisi, Alexander Sumaroka, Luis Felipe Marinho, Tatyana Appelbaum,[...]. Proc Natl Acad Sci U S A 2018
81
11

Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa.
M Dominik Fischer, Michelle E McClements, Cristina Martinez-Fernandez de la Camara, Julia-Sophia Bellingrath, Daniyar Dauletbekov, Simon C Ramsden, Doron G Hickey, Alun R Barnard, Robert E MacLaren. Mol Ther 2017
66
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.